Kepal N. Patel, MD

  • Specialties: Endocrine Surgery, Head & Neck Surgery
  • Language: English
  • Phone: 212-263-7710

About Me

Conditions and Treatments

thyroid cancer, thyroid nodule, hyperparathyroidism, parathyroid disease, hyperthyroidism, thyroid diseases, head and neck cancer, head and neck tumors, salivary gland tumor, parotid diseases, neck mass, oral cancer, submandibular gland tumor, adenoid cystic carcinoma, laryngeal cancer, mucoepidermoid carcinoma, squamous cell cancer, orbit tumor, adenocarcinoma, melanoma, skin cancer, eyelid tumor, basal cell cancer, thyroid surgery, parathyroidectomy, neck surgery, surgery, neck exploration, parathyroid surgery
Show More Conditions

Credentials

Positions
  • Associate Professor, Department of Surgery
  • Associate Professor, Department of Biochemistry and Molecular Pharmacology
  • Associate Professor, Department of Otolaryngology-Head and Neck Surgery
  • Dir Division of Endocrine Surgery
Board Certifications
  • American Board of Surgery - Surgery, 2003
Education and Training
  • Fellowship, Memorial Sloan-Kettering Cancer Center, Head & Neck, 2004
  • Residency, Robert Wood Johnson Univ. Hosp., Surgery (General), 2002
  • MD from Univ. Medicine & Dentistry NJ, 1996

Locations and Appointments

71 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • American Imaging Network
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield HealthPlus
  • Empire Blue Cross Blue Shield HealthPlus Essential
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Essential
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Essential
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Essential
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare Core and Charter
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Village Caremax
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
  • Wellcare Exchange
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Endocrine Surgery Associates

530 1st Avenue, Suite 6H
New York, NY 10016

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

The optimal management of thyroid cancer is dependent on the assessment of the malignant potential of the individual tumor at presentation. Understanding the genetic mechanisms controlling thyroid tumor progression can provide valuable prognostic markers and potential therapeutic targets. Our research focuses on the changes in intracellular molecular pathways that lead to the progression of thyroid cancer. When these pathways are understood, specific drugs can be developed to block these changes. By comparing genomic differences between different thyroid cancers, our laboratory has identified genes that may play a role in determining their behavior. Furthermore, we have identified molecular factors that potentially promote thyroid cancer metastases. We are developing new strategies to target the genes associated with aggressive thyroid cancer behavior. By understanding the biology of individual tumors, we will be able to create personalized cancer treatment plans for our patients. I have joint appointments in Surgery and Biochemistry, and have been recruited to lead the endocrine surgery research program.

Publications

  • Noninvasive Encapsulated Follicular Variant of Papillary Thyroid "Cancer" (or Not): Time for a Name Change

    Patel, Kepal N
    JAMA oncology. 2016 Apr 14. ?-?

  • Method of Detection of Well-Differentiated Thyroid Cancers in Obese and Non-Obese Patients

    Zagzag, Jonathan; Malone, Michael K; Lopresti, Melissa A; Ogilvie, Jennifer B; Patel, Kepal N; Heller, Keith S
    PLoS one. 2016 Apr 4. 11 (4): e0152768-e0152768 e0152768

  • American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making

    Ferris, Robert L; Baloch, Zubair; Bernet, Victor; Chen, Amy; Fahey, Thomas J 3rd; Ganly, Ian; Hodak, Steven P; Kebebew, Electron; Patel, Kepal N; Shaha, Ashok; Steward, David L; Tufano, Ralph P; Wiseman, Sam M; Carty, Sally E
    Thyroid. 2015 Jun 24. 25 (7): 760-768

Read All Publications (27)